title: Comparison of hypertension management between cancer survivors and the general public.
abstract: Proper management of hypertension is important for better survival and quality of life of cancer survivors who have hypertension. We aimed to compare hypertension management between cancer survivors and the general population. A nationwide, multicenter, cross-sectional survey was administered to adult cancer patients, currently receiving treatment or follow-up, who had been diagnosed with hypertension. Comparison group was selected from among participants in the health behavior survey of the third Korean National Health and Nutrition Examination Survey. Self-reported hypertension management was surveyed, including antihypertensive medication adherence, frequency of blood pressure (BP) monitoring and perceived BP control. Multivariate logistic regression analysis was used to evaluate the relationship between cancer survivorship and each outcome measure. Compared with the general population, cancer survivors were more likely to report full adherence (92.7% vs. 73.0%; adjusted odds ratio (aOR)=3.45; 95% confidence interval (CI), 2.08-5.73), more frequent BP measurement (≥ 24 per year: 50.1% vs. 24.7%; aOR=2.51; 95% CI, 1.83-3.46), and very good perceived BP control (60.8% vs. 26.2%; aOR=4.34; 95% CI, 3.13-6.02). Cancer survivors appear to be better with antihypertensive medication adherence and BP monitoring than those without cancer, and as a result, they appear to be under better BP control. However, several methodological limitations of our study prompt further research on this issue.
authors.affiliation: 1] Department of Family Medicine & Health Promotion Center, Seoul National University Hospital, Seoul, Republic of Korea [2] Cancer Survivorship Clinic, Seoul National University Cancer Hospital, Seoul, Republic of Korea.
authors.forename: Dong
authors.initials: D
authors.lastname: Wook Shin
authors.forename: So
authors.initials: S
authors.lastname: Young Kim
authors.forename: Juhee
authors.initials: J
authors.lastname: Cho
authors.forename: Hyung
authors.initials: H
authors.lastname: Kook Yang
authors.forename: Belong
authors.initials: B
authors.lastname: Cho
authors.forename: Hae-Sung
authors.initials: HS
authors.lastname: Nam
authors.forename: Heon
authors.initials: H
authors.lastname: Kim
authors.forename: Jong-Hyock
authors.initials: JH
authors.lastname: Park
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001795:Blood Pressure Determination; D019090:Case Management; D003710:Demography; D019468:Disease Management; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007723:Korea; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D010349:Patient Compliance; D017741:Survivors; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents